Search Results 81-90 of 21344 for anti-TNF drugs

  1. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

    "When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...

  2. COVID-19 drugs: Are there any that work? - Mayo Clinic

    The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems. Medicines to treat COVID- ...

  3. A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients ... adalimumab, a tumor necrosis ...

  4. A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess the long-term safety and effectiveness of repeat treatment with adalimumab in pediatric patients who have ulcerative ...

  5. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    18-80 years of age, inclusive · Moderately to severely active UC as determined by the Mayo Clinic Score assessment (MCS) · Naive to treatment with any anti-TNF ...

  6. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Proper Use - Mayo Clinic

    If certain kinds of infection are present, using this medicine may make the infection worse and possibly lead to eye damage. Dosing. The dose medicines in this ...

  7. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with ...

  8. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...

  9. Microscopic colitis - Diagnosis and treatment - Mayo Clinic

    Biologic medicines, such as infliximab (Remicade), adalimumab (Humira) or vedolizumab (Entyvio). These can reduce swelling and irritation in the colon. Surgery.

  10. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...